Hepatitis C Infection in Patients with Primary Hypogammaglobulinemia after Treatment with Contaminated Immune Globulin
New England Journal of MedicinePublished 15 December 1994
Kristian Bjøro, Stig S. Frøland, Zhibing Yun, Helvi Holm Samdal, Terese Haaland
Citations381
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In patients with primary hypogammaglobulinemia there was a high rate of HCV infection after treatment with contaminated immune globulin, and responses to interferon are poor.
Abstract
In patients with primary hypogammaglobulinemia there was a high rate of HCV infection after treatment with contaminated immune globulin. In these immunocompromised patients HCV infection has a severe and rapidly progressive course, and responses to interferon are poor.
Keywords
Immunology and MicrobiologyMedicine
Analytical BiochemistrySingle-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
63,238 Citations1987Piotr Chomczynski
Analytical BiochemistrySingle-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
46,819 Citations1987Piotr Chomczyński, Nicoletta Sacchi
A new method of total RNA isolation by a single extraction with an acid guanidinium thiocyanate-phenol-chloroform mixture is described, providing a pure preparation of undegraded RNA in high yield and can be completed within 4 h.
NatureAvoiding false positives with PCR
3,491 Citations1989Shirley Kwok, Russell Higuchi
The exquisite sensitivity of the polymerase chain reaction means DNA contamination can ruin an entire experiment and adherence to a strict set of protocols can avoid disaster.
Journal of General VirologyClassification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
1,383 Citations1993Peter Simmonds, Bruce Irvine +8 more
New England Journal of MedicineLong-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
685 Citations1992Leonard B. Seeff, Zelma Buskell‐Bales +10 more
There was no increase in mortality from all causes after transfusion-associated non-A, non-B hepatitis, although there was a small but statistically significant increase in the number of deaths related to liver disease.
HepatologyHepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease
565 Citations1994Geoffrey Dusheiko, Hemda Schmilovitz‐Weiss +6 more
The data suggest significant geographic clustering of type 4 disease in the Middle East area and poor response to interferon‐α was noted in patients with type 1 disease, which may have important clinical implications.
Journal of General VirologyCharacterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection
390 Citations1993Hiroaki Okamoto, Hajime Tokita +5 more
Four new hepatitis C virus isolates are identified whose genomic RNA could be amplified by PCR using primers from the 5' untranslated region (UTR), but the RNA could not be detected with genotype I to IV (or types 1a, 1b, 2a and 2b respectively)-specific core region-derived primers.
Annals of Internal MedicineDecrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C
383 Citations1991Michiko Shindo, Adrian M. Di Bisceglie +5 more
Journal of Clinical ImmunologyClinical and immunologic analyses of 103 patients with common variable immunodeficiency
348 Citations1989Charlotte Cunningham‐Rundles
Journal of HepatologyInterferon for non-A, non-B chronic hepatitis
294 Citations1991Fabio Tinè, S. Magrin +2 more
It is concluded that larger trials are needed to identify an optimal schedule of treatment and to evaluate predictors of interferon effectiveness in patients with non-A, non-B chronic hepatitis.
The LancetNON-A, NON-B HEPATITIS OCCURRING IN AGAMMAGLOBULINAEMIC PATIENTS AFTER INTRAVENOUS IMMUNOGLOBULIN
216 Citations1984Andrew Lever, David J. Brown +2 more
The finding that the virus can be transmitted in IgG concentrates suggests either that the general population has a very low level of antibodies to the putative virus or that such antibodies are not virus-neutralising.
HepatologyDetection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α
214 Citations1992Hideki Hagiwara, Norio Hayashi +6 more
Therapy with interferon‐α appears to be beneficial in chronic hepatitis C because of its suppressive effects on hepatitis C virus replication.
New England Journal of MedicineAbnormalities of Immunoregulatory T Cells in Disorders of Immune Function
213 Citations1979Ellis L. Reinherz, Arye Rubinstein +4 more
It is concluded that the characterization of T cells may provide insight into the causes of a number of abnormal immune states in man.
The American Journal of MedicineIntravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency
156 Citations1988Janne Björkander, Charlotte Cunningham-Rundles +4 more
Sixteen of 77 patients with common variable immunodeficiency or IgG subclass deficiency contracted non-A, non-B hepatitis in association with intravenous infusions of immunoglobulin, and the hepatitis seemed to run a more severe course in these patients than in non-immunodeficient patients.
New England Journal of MedicineHepatitis C Serotype and Response to Interferon Therapy
136 Citations1994Liliana Chemello, A. Albertí +2 more
To the Editor: Hepatitis C virus (HCV) is a major cause of chronic liver disease and of hepatocellular carcinoma; several strains of HCV exist; distinct genotypes can be identified by sequence comparison of the viral genomes.
GutNatural history of AIDS related sclerosing cholangitis: a study of 20 cases.
132 Citations1993Alastair Forbes, C Blanshard +1 more
A case control study of AIDS related sclerosing cholangitis indicates that it has no overall influence on prognosis, but is responsible for a striking reversal of the usual inverse correlation of age and survival in HIV infection.
The LancetALPHA-INTERFERON THERAPY FOR NON-A, NON-B HEPATITIS TRANSMITTED BY GAMMAGLOBULIN REPLACEMENT THERAPY
118 Citations1987Brian J. Thomson, Andrew Lever +2 more
Three hypogammaglobulinaemic patients with non-A, non-B hepatitis transmitted by gammagLobulin replacement therapy were treated with lymphoblastoid alpha-interferon and all showed a striking improvement in serum aminotransferases after the start of each course of treatment.
TransfusionPartitioning of hepatitis C virus during Cohn‐Oncley fractionation of plasma
88 Citations1992S Yei, M.W. Yu +1 more
It is suggested that the safety of immune globulins with respect to HCV transmission is not due solely to the partitioning of HCV away from the immunoglobulin fraction.
Vox SanguinisTransmission of Non‐A, Non‐B Hepatitis by pH4‐Treated Intravenous Immunoglobulin
73 Citations1989P.E. Williams, P.L. Yap +4 more
The transmission of NANBH by one of approximately 110 batches administered demonstrates the importance of continued close surveillance of recipients of IV IgG, even if asymptomatic, by regular monitoring of liver function tests and recording of all batches received.
The LancetPrimary antibody deficiency in adults
68 Citations1991G Spickett, Siraj Misbah +1 more
Although all primary immunodeficiencies are rare, IgA deficiency has an estimated frequency of between 1 in 320 and 1 in 800, and consequences of delayed diagnosis are serious: in a study of 32 patients with primary antibody deficiency, more than two-thirds experienced diagnostic delay leading to serious morbidity.
Journal of Medical VirologyDetection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in swedish blood donors
67 Citations1993Zhibing Yun, Gudrun Lindh +3 more
Most patients with antibodies to two or more HCV antigens by RIBA will have a chronic replicative HCV infection associated with viraemia, and HCV virAemia can also be present in some patients, who have antibodies to only one HCV antigen particularly the C22 epitope.
Clinical & Experimental ImmunologyRaised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features
42 Citations1992Pål Aukrust, Stig S. Frøland +1 more
High neopterin levels are thought to be a marker for hyperactivity in monocytes/macrophages, and dysfunction of these cells may therefore be associated with fundamental immune pathology in some subgroups of primary hypogammaglobulinaemia.
Scandinavian Journal of GastroenterologyLiver Disease in Anti-Hepatitis C Virus-Positive Norwegian Blood Donors
16 Citations1994Ingvild Nordøy, E. Schrumpf +5 more
It is confirmed that the presence of anti-HCV (second generation) usually, and HCV-RNA always, seems to indicate ongoing infection--also when alanine aminotransferase levels are normal, and suggests that low-activity hepatitis, evaluated by ALAT levels, may indicate a milder disease.
The Journal of Infectious DiseasesHepatitis C Virus Genotypes in Chronic Hepatitis and Response to Interferon- Therapy
14 Citations1993V. Gérolami, P. Hallon +7 more
Vox SanguinisHepatitis C Virus (HCV) RNA among Anti-HCV-Positive Blood Donors and Their Recipients
12 Citations1993Kjell Skaug, Huayi Li +3 more
All the EIA‐2‐positive sera showed reactivity in Ortho's recombinant immunoblot assay (RIBA‐2), but 5 of the 28 recipients and 1 of the donors reacted with only one band (RIba‐2 indeterminate).
Immunological InvestigationsViruses and Antibody Deficiency Syndromes
10 Citations1988A D Webster, Gavin P Spickett +2 more
Retrovirus isolations from blood mononuclear cells of 3 out of 31 patients with common variable hypogammaglobulinemia support the concept that some of the non-familial "primary" immunodeficiencies may be due to retrovirus infections.
Serodiagnosis and Immunotherapy in Infectious DiseaseNon-A, non-B hepatitis associated with the administration of intravenous immunoglobulin—transmission studies in chimpanzees
10 Citations1987Sten Iwarson, Rune Wejstål +5 more
Chimpanzee 1279 developed tubular structures of the C-III type concomitantly with its later ALT elevations, suggesting the possibility that the serum inoculum contained two NANBH agents and thus that the intravenous immunoglobulin itself may have been contaminated with two NANAH agents.